When this expertise matters
- The product is approaching an NHS pilot, procurement, framework or adoption conversation and needs a credible DTAC V2 evidence pack.
- A previous DTAC response was built around the older form and needs to be reviewed against the v2 baseline now in use from 6 April 2026.
- Clinical safety, data protection, technical security, interoperability, usability and accessibility evidence exists, but it is fragmented across teams.
- The product sits on the boundary between digital health technology, SaMD, AI health technology or connected medical device software.
- NHS buyers, ICBs, trusts or evaluation partners are asking for assurance evidence before commercial deployment can move.
